All In Biotech

Drug Trial Radar · NCT06698003

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

A Phase 2 Study for Screening and Prevention of Adult T-cell Leukemia/Lymphoma With Mogamulizumab in High-Risk Carriers of HTLV-1

Last checked: Nov 20, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

134

Planned (sponsor's estimate)

Start

Nov 15, 2024

Primary completion

Nov 15, 2029

Study completion Nov 15, 2029

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for this type of cancer because they are infected with the HTLV-1 virus and because of changes seen in some of their immune system cells called T-cells.

Conditions

  • T-Cell Leukemia/Lymphoma, Adult
  • T-cell Leukemia/Lymphoma
  • T-cell Leukemia
  • Lymphoma

Interventions

  • MogamulizumabDrug

    Cohort 1: 0.3 mg/kg of mogamulizumab every 12 weeks, for 2 total doses Cohort 2: 0.3 mg/kg of mogamulizumab every 6 weeks, for 4 total doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Minimum dose and schedule of mogamulizumab to reduce the proviral load by ≥75%Time frame: 6 months from baseline

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Memorial Sloan Kettering at Basking Ridge (All protocol activities)

    Basking Ridge, New Jersey · Recruiting

  • Memorial Sloan Kettering Monmouth (All protocol activities)

    Middletown, New Jersey · Recruiting

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, New Jersey · Recruiting

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities)

    Commack, New York · Recruiting

  • Memorial Sloan Kettering Westchester (All protocol activities)

    Harrison, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York · Recruiting

  • Memorial Sloan Kettering Nassau (All protocol activities)

    Uniondale, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.